Research methods in drug surveillance

Pharmacopsychiatry

Volumn 37, Issue SUPPL. 1, 2004, Pages

  Engel, R R ^a,c   Grohmann, R ^a   Ruther E ^b   Hippius, H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ANALYTICAL ERROR; ARTICLE; CASE CONTROL STUDY; CASE REPORT; COHORT ANALYSIS; COMPARATIVE ANATOMY; DRUG APPROVAL; DRUG SURVEILLANCE PROGRAM; HUMAN; METHODOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOLOGY; RETROSPECTIVE STUDY; COMPARATIVE STUDY; DRUG MONITORING; POSTMARKETING SURVEILLANCE; RESEARCH; STATISTICAL ANALYSIS;

DRUG;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CASE-CONTROL STUDIES; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DRUG MONITORING; HUMANS; PHARMACEUTICAL PREPARATIONS; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH;

EID: 2442673932     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Andrew JE, Prescott P, Smith TM, Inman WH, Kubota K. Testing for adverse reactions using prescription event monitoring. Stat Med 1996; 15: 987-1002
2. Ashby D, Smyth RL, Brown PJ. Statistical issues in pharmacoepidemiological case-control studies. Stat Med 1998; 17: 1839-1850
3. CIOMS. Guidelines for Preparing Core Clinical Safety Information on Drugs. Report from CIOMS Working Group III. Genf: WHO, 1995
4. Greil W, Horvath A, Sassim N, Erazo N, Grohmann R. Disinhibition of libido: an adverse effect of SSRI? J Affect Disord 2001; 62: 225-228
5. Grohmann R, Engel R, Rüther E, Hippius H. The AMSP Drug Safety Program: Methods and Global Results. Pharmacopsychiatry 2004; 37 Suppl 1: S4-11
6. Grohmann R, Hippius H, Helmchen H, Rüther E, Schmidt LG. The AMÜP study for drug surveillance in psychiatry - a summary of inpatient data. Pharmacopsychiatry 2004; 37 Suppl 1: S16-26
7. Heeley E, Riley J, Layton D, Wilton LV, Shakir SAW. Prescription-event monitoring and reporting of ad verse drug reactions. Lancet 2001; 358: 1872-1873
8. Heeley E, Wilton LV, Shakir SAW. Automated signal generation in Prescription-Event Monitoring. Drug Safety 2002; 25: 423-432
9. Inman WHW. Monitoring for Drug Safety. Philadelphia: J. B. Lippincott Co, 1980
10. Koster MC, Teeuw B, Cockburn I. Compliance in European pharmacovigilance: How compliant is compliant? Pharmacoepidemiology and Drug Safety 2000; 9: 473-478
11. Mann RD, Wilton LV, Pearce GL, Mackay FJ, Dunn NR. Prescription-event monitoring (PEM) in 1996 - A method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiology and Drug Safety 1997; 6 (Suppl. 3): S5-11
12. Stübner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H et al. Pisa syndrome (Pleurothotonus): Report of a multicenter drug safety surveillance project. J. Clin. Psychiatry 2000; 61: 569-574
13. Wolstein J, Grohmann R, Rüther E, Hippius H. Antipsychotic drugs and venous thromboembolism. Lancet 2000; 356: 252